C12N 2720/10051
Methods of production or purification of viral material
C12N2720/10051 (Methods of production or purification of viral material) appears on 9 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 8
- Assignees
- 10
- Inventors
- 22
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 2 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Serum-free medium for avian vaccine production and uses thereof14 Oct 2025US 12,441,989 B2Boehringer Ingelheim Vetmedica GmbH
- Methods of producing viruses22 Oct 2019US 10,450,544 B2Benchmark Animal Health Limited
- Recombinant Marek's disease viruses and uses thereof29 Jan 2019US 10,188,720 B2Ceva Sante Animale
- Method for selecting a permissive cell line for replicating avian viruses21 Aug 2018US 10,053,672 B2Institut National de la Recherche Agronomique
- Process and formulation for immunizing fish in aquaculture systems17 Jun 2014US 8,753,878 B2Ewos S.A.
- Serum-free medium for avian vaccine production and uses thereof16 Jun 2022US 2022/0186191 A1Boehringer Ingelheim Animal Health USA Inc.
- Methods of producing viruses7 Feb 2019US 2019/0040354 A1Benchmark Animal Health Limited
- Recombinant marek's disease viruses and uses thereof4 Aug 2016US 2016/0220657 A1Ceva Sante Animale
- Method for selecting a permissive cell line for replicating avian viruses2 Jun 2016US 2016/0152956 A1Institut National de la Recherche Agronomique
- Process and Formulation for Immunizing Fish in Aquaculture Systems14 Apr 2011US 2011/0086087 A1Ewos S.A.
Most cited
By later US patents
- Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants16US 6,569,422 B1Akzo Nobel N. V. · 2003
- Genetically engineered cell culture adapted infectious bursal disease virus (IBDV) mutants14US 6,492,148 B1Akzo Nobel N. V. · 2002
- Method for generating birnavirus from synthetic RNA transcripts11US 5,871,744 AUniversity of Maryland-Biotechnology Inst. · 1999
- Recombinant Marek's disease viruses and uses thereof4US 10,188,720 B2Ceva Sante Animale · 2019
- Method to produce inactivated w/o emulsion adjuvated vaccines4US 6,458,363 B1Akzo Nobel N. V. · 2002